StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Eli Lilly and Company
NYSE:LLY
Sector
Location
Market Cap
USD 700.84 B
Share Price
USD 780.67
Avg Daily Volume
4,188,687
Change (1 day)
0.18%
Change (1 year)
-13.08%
Change (YTD)
1.12%
Eli Lilly and Company Total Assets for the year ending December 31, 2024: USD 78.71 B
Eli Lilly and Company Total Assets is USD 78.71 B for the year ending December 31, 2024, a 22.98% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Eli Lilly and Company Total Assets for the year ending December 31, 2023 was USD 64.01 B, a 29.33% change year over year.
-
Eli Lilly and Company Total Assets for the year ending December 31, 2022 was USD 49.49 B, a 1.40% change year over year.
-
Eli Lilly and Company Total Assets for the year ending December 31, 2021 was USD 48.81 B, a 4.66% change year over year.
-
Eli Lilly and Company Total Assets for the year ending December 31, 2020 was USD 46.63 B, a 18.70% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%
Haleon plc
USD 5.15
HLN.L
+0.06
1.17%
Daiichi Sankyo Company, Limited
USD 22.30
4568.T
+0.05
0.21%
UCB SA
USD 198.80
UCB.BR
+6.47
3.36%
Hansoh Pharmaceutical Group Company Limited
USD 3.97
3692.HK
+0.09
2.44%
Teva Pharmaceutical Industries Limited
USD 17.20
TEVA.TA
+0.20
1.20%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%
Haleon plc
USD 5.15
HLN.L
+0.06
1.17%
Daiichi Sankyo Company, Limited
USD 22.30
4568.T
+0.05
0.21%
UCB SA
USD 198.80
UCB.BR
+6.47
3.36%
Hansoh Pharmaceutical Group Company Limited
USD 3.97
3692.HK
+0.09
2.44%
Teva Pharmaceutical Industries Limited
USD 17.20
TEVA.TA
+0.20
1.20%